2-hydroxy-N-methylsuccinimide: structure given in first source
ID Source | ID |
---|---|
PubMed CID | 260809 |
SCHEMBL ID | 4711905 |
MeSH ID | M0280529 |
Synonym |
---|
NCIOPEN2_001425 |
19948-27-7 |
nsc92546 |
nsc-92546 |
2-hydroxy-n-methylsuccinimide |
3-hydroxy-1-methylpyrrolidine-2,5-dione |
AKOS006229662 |
FT-0605209 |
1-methyl-3-hydroxysuccinimide |
3-hydroxy-1-methyl-pyrrolidine-2,5-dione |
SCHEMBL4711905 |
2,5-pyrrolidinedione, 3-hydroxy-1-methyl- |
succinimide, 2-hydroxy-n-methyl- |
9XH7E7CQN4 , |
3-hydroxy-1-methyl-2,5-pyrrolidinedione |
3-hydroxy-n-methylsuccinimide |
AMY30563 |
AT19102 |
SB47296 |
EN300-126780 |
unii-9xh7e7cqn4 |
DTXSID201028009 |
mfcd04118117 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.15) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (11.11%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |